AT373878B - Verfahren zur herstellung von n-aryl-n'-(2 -imidazolidinyliden)-harnstoffen und deren salzen - Google Patents

Verfahren zur herstellung von n-aryl-n'-(2 -imidazolidinyliden)-harnstoffen und deren salzen

Info

Publication number
AT373878B
AT373878B AT0808979A AT808979A AT373878B AT 373878 B AT373878 B AT 373878B AT 0808979 A AT0808979 A AT 0808979A AT 808979 A AT808979 A AT 808979A AT 373878 B AT373878 B AT 373878B
Authority
AT
Austria
Prior art keywords
imidazolidinylides
ureas
aryl
salts
producing
Prior art date
Application number
AT0808979A
Other languages
English (en)
Other versions
ATA808979A (de
Original Assignee
Mcneilab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/972,579 external-priority patent/US4229462A/en
Priority claimed from US05/972,580 external-priority patent/US4239768A/en
Application filed by Mcneilab Inc filed Critical Mcneilab Inc
Publication of ATA808979A publication Critical patent/ATA808979A/de
Application granted granted Critical
Publication of AT373878B publication Critical patent/AT373878B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/30—Isothioureas
    • C07C335/38—Isothioureas containing any of the groups, X being a hetero atom, Y being any atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/42—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44—Nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT0808979A 1978-12-22 1979-12-21 Verfahren zur herstellung von n-aryl-n'-(2 -imidazolidinyliden)-harnstoffen und deren salzen AT373878B (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US05/972,579 US4229462A (en) 1978-12-22 1978-12-22 Method for controlling hypertension and compositions
US05/972,580 US4239768A (en) 1978-12-22 1978-12-22 Method for relieving irritable bowel syndrome symptoms

Publications (2)

Publication Number Publication Date
ATA808979A ATA808979A (de) 1983-07-15
AT373878B true AT373878B (de) 1984-02-27

Family

ID=27130555

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0808979A AT373878B (de) 1978-12-22 1979-12-21 Verfahren zur herstellung von n-aryl-n'-(2 -imidazolidinyliden)-harnstoffen und deren salzen

Country Status (23)

Country Link
AT (1) AT373878B (de)
AU (2) AU532332B2 (de)
CA (1) CA1127651A (de)
CH (1) CH647236A5 (de)
DE (1) DE2951213A1 (de)
DK (1) DK548179A (de)
ES (1) ES487159A0 (de)
FI (1) FI66354C (de)
FR (2) FR2444462B1 (de)
GB (2) GB2040681B (de)
GR (1) GR68018B (de)
HU (1) HU183013B (de)
IL (1) IL59019A (de)
IT (1) IT1126839B (de)
NL (1) NL7909265A (de)
NO (1) NO794249L (de)
NZ (1) NZ192453A (de)
PH (1) PH16571A (de)
PT (1) PT70624A (de)
SE (1) SE7910612L (de)
SU (1) SU971098A3 (de)
YU (1) YU314979A (de)
ZW (1) ZW25379A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4673680A (en) * 1985-09-18 1987-06-16 Pendleton Robert G α2 -adrenergic receptor antagonists as modifiers of gastrointestinal motility
US11516649B2 (en) * 2018-10-29 2022-11-29 Apple Inc. Mechanism to activate and manage a standalone device for cellular service

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1296962A (fr) * 1960-08-05 1962-06-22 Geigy Ag J R Nouveaux composés 2-imino-1.3-di-aza et leur préparation
NL288408A (de) * 1960-08-05

Also Published As

Publication number Publication date
IL59019A (en) 1984-05-31
AU566013B2 (en) 1987-10-08
GR68018B (de) 1981-10-27
FR2445321A1 (de) 1980-07-25
FR2445321B1 (de) 1983-08-26
NL7909265A (nl) 1980-06-24
GB2040681A (en) 1980-09-03
GB2040681B (en) 1983-04-13
IL59019A0 (en) 1980-03-31
DE2951213A1 (de) 1980-07-10
FI66354B (fi) 1984-06-29
FR2444462A1 (fr) 1980-07-18
AU1640083A (en) 1983-11-17
ZW25379A1 (en) 1981-07-22
ES8101558A1 (es) 1980-12-16
NZ192453A (en) 1982-09-07
FI794036A (fi) 1980-06-23
GB2113204B (en) 1984-02-01
SE7910612L (sv) 1980-06-23
HU183013B (en) 1984-04-28
CA1127651A (en) 1982-07-13
ES487159A0 (es) 1980-12-16
IT7951164A0 (it) 1979-12-21
YU314979A (en) 1983-02-28
ATA808979A (de) 1983-07-15
PT70624A (en) 1980-01-01
NO794249L (no) 1980-06-24
DK548179A (da) 1980-06-23
CH647236A5 (de) 1985-01-15
FR2444462B1 (fr) 1986-08-29
AU532332B2 (en) 1983-09-29
PH16571A (en) 1983-11-18
SU971098A3 (ru) 1982-10-30
GB2113204A (en) 1983-08-03
FI66354C (fi) 1984-10-10
IT1126839B (it) 1986-05-21
AU5378079A (en) 1980-06-26

Similar Documents

Publication Publication Date Title
AT384805B (de) Verfahren zur herstellung von neuen 1,2-diaminocyclobuten-3,4-dionen und deren salzen
DE3484834D1 (de) Verfahren zur herstellung von polyamidiminen und deren verwendung.
ATA122485A (de) Verfahren zur herstellung von neuen 1,4-dihydro-4-oxonaphthyridin-derivaten und deren salzen
AT361914B (de) Verfahren zur herstellung von neuen hetero- cyclischen 1-aryloxy-2-hydroxy-3-alkylenamino- propanen und deren salzen
ATA183877A (de) Verfahren zur herstellung neuer n-(5- tetrazolyl)-4-oxo-4h-pyrimido(2,1-b)benzo- thiazol-3-carboxamide und von deren salzen
AT372956B (de) Verfahren zur herstellung von 2-aminopyrimidonen und von deren salzen
AT355018B (de) Verfahren zur herstellung von neuen 1,2- benzisothiazolinonen und von deren salzen
DD132964A5 (de) Verfahren zur herstellung neuer substituierter 2-phenylamino-imidazoline-(2)und deren saeureadditionssalze
ATA902383A (de) Verfahren zur herstellung neuer 2,3,4-trinor-1,5 -inter-m-phenylen-prostacyclin-i2-analoga und von deren salzen
ATA353377A (de) Verfahren zur herstellung von neuen (1,2- dihydro-2-oxo-nicotinamido)-alkyl-benzol- sulfonylharnstoffen und von deren salzen
AT370728B (de) Verfahren zur herstellung von pyrimidinverbindungen und von deren salzen
ATA301083A (de) Verfahren zur herstellung neuer benzamidderivate und von deren salzen
AT373878B (de) Verfahren zur herstellung von n-aryl-n'-(2 -imidazolidinyliden)-harnstoffen und deren salzen
AT375069B (de) Verfahren zur herstellung der (2,2-dimethyl-1,2dihydro-chinolin-4-yl)-methyl-sulfon-s[ure und von deren salzen
AT370083B (de) Verfahren zur herstellung von neuen aminen und deren salzen
AT384806B (de) Verfahren zur herstellung von neuen 4-aryl-2-methyl-1,2,3,4-tetrahydro-isochinolinderivaten und deren salzen
AT350520B (de) Verfahren zur herstellung von neuen 7-amino- methyl-5,6,7-trihydro-2-substituierten-benzo- cyclohept-8-enen sowie deren saeureadditions- salzen
ATA296479A (de) Verfahren zur herstellung von neuen (1,2- dihydro-2-oxo-nicotinamido)-alkylbenzolsul- fonylharnstoffen und von deren salzen
ATA296279A (de) Verfahren zur herstellung von neuen (1,2- -dihydro-2-oxo-nicotinamido)-alkylbenzosulfo- nylharnstoffen und von deren salzen
AT374804B (de) Verfahren zur herstellung von 14-oxo-15-hydroxy- imino-e-homoeburnan und den saeureadditionssalzen davon
AT387216B (de) Verfahren zur herstellung von 2,4-diamino-5benzyl-pyrimidin-derivaten und deren saeureadditionssalzen
DD138316A5 (de) Verfahren zur herstellung von substituierten 4,4'-biphenylylen-bis(2-thioureylen)-di-naphthalintrisulfonsaeuren und salzen davon
ATA296379A (de) Verfahren zur herstellung von neuen (1,2- dihydro-2-oxo-nicotinamido)-alkylbenzolsul- fonylharnstoffen und von deren salzen
ATA820179A (de) Verfahren zur herstellung von disulfidverbindungen und von deren salzen
ATA441280A (de) Verfahren zur herstellung von neuen substituierten n-phenyl-n'-(2-chlor-6-fluor-benzoyl)-harnstoff n